These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hydrogel-forming microarray patches with cyclodextrin drug reservoirs for long-acting delivery of poorly soluble cabotegravir sodium for HIV Pre-Exposure Prophylaxis. Volpe-Zanutto F; Vora LK; Tekko IA; McKenna PE; Permana AD; Sabri AH; Anjani QK; McCarthy HO; Paredes AJ; Donnelly RF J Control Release; 2022 Aug; 348():771-785. PubMed ID: 35738464 [TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study. Kshirsagar SJ; Bhalekar MR; Mohapatra SK Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303 [TBL] [Abstract][Full Text] [Related]
4. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies. Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361 [TBL] [Abstract][Full Text] [Related]
5. Elucidating the Impact of Surfactants on the Performance of Dissolving Microneedle Array Patches. Anjani QK; Sabri AHB; Utomo E; Domínguez-Robles J; Donnelly RF Mol Pharm; 2022 Apr; 19(4):1191-1208. PubMed ID: 35235330 [TBL] [Abstract][Full Text] [Related]
8. Development of Norelgestromin Dissolving Bilayer Microarray Patches for Sustained Release of Hormonal Contraceptive. Vora LK; Tekko IA; Volpe Zanutto F; Sabri A; Choy RKM; Mistilis J; Kwarteng P; Kilbourne-Brook M; Jarrahian C; McCarthy HO; Donnelly RF Pharmaceutics; 2024 Jul; 16(7):. PubMed ID: 39065643 [TBL] [Abstract][Full Text] [Related]
9. Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation. Pokharkar V; Khanna A; Venkatpurwar V; Dhar S; Mandpe L Acta Pharm; 2009 Jun; 59(2):121-32. PubMed ID: 19564138 [TBL] [Abstract][Full Text] [Related]
10. Soluplus®-based dissolving microarray patches loaded with colchicine: towards a minimally invasive treatment and management of gout. Anjani QK; Sabri AHB; Moreno-Castellanos N; Utomo E; Cárcamo-Martínez Á; Domínguez-Robles J; Wardoyo LAH; Donnelly RF Biomater Sci; 2022 Oct; 10(20):5838-5855. PubMed ID: 35972236 [TBL] [Abstract][Full Text] [Related]
11. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin. Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740 [TBL] [Abstract][Full Text] [Related]
12. Development of carvedilol-cyclodextrin inclusion complexes using fluid-bed granulation: a novel solid-state complexation alternative with technological advantages. Alonso EC; Riccomini K; Silva LA; Galter D; Lima EM; Durig T; Taveira SF; Martins FT; Cunha-Filho MS; Marreto RN J Pharm Pharmacol; 2016 Oct; 68(10):1299-309. PubMed ID: 27465985 [TBL] [Abstract][Full Text] [Related]
13. Cyclodextrin-based poly(pseudo)rotaxanes for transdermal delivery of carvedilol. Taveira SF; Varela-Garcia A; Dos Santos Souza B; Marreto RN; Martin-Pastor M; Concheiro A; Alvarez-Lorenzo C Carbohydr Polym; 2018 Nov; 200():278-288. PubMed ID: 30177168 [TBL] [Abstract][Full Text] [Related]
14. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems. Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117 [TBL] [Abstract][Full Text] [Related]
15. Studies on formulation development of mouth dissolving tablets of Carvedilol. Pokharkar V; Dhar S; Mandpe L Hindustan Antibiot Bull; 2007 Feb-2008 Nov; 49-50(1-4):21-8. PubMed ID: 19957540 [TBL] [Abstract][Full Text] [Related]
18. Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate. Tekko IA; Chen G; Domínguez-Robles J; Thakur RRS; Hamdan IMN; Vora L; Larrañeta E; McElnay JC; McCarthy HO; Rooney M; Donnelly RF Int J Pharm; 2020 Aug; 586():119580. PubMed ID: 32593650 [TBL] [Abstract][Full Text] [Related]
19. Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin. Wen X; Tan F; Jing Z; Liu Z J Pharm Biomed Anal; 2004 Feb; 34(3):517-23. PubMed ID: 15127807 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes. Patel SG; Rajput SJ AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]